Global spending on prescription drugs to top $1 trillion by 2017, report saysBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6997 (Published 21 November 2013) Cite this as: BMJ 2013;347:f6997
- Michael McCarthy
Driven by the world’s expanding middle class and economic growth in developing nations, global spending on prescription medicines will likely reach $1.2 trillion (£0.7 trillion; €0.9 trillion) by 2017, an increase of $205bn-$235bn from 2012, says a new report by the IMS Institute for Healthcare Informatics, a healthcare industry consulting group.1
However, growth rates will differ substantially between the developed markets of North America, Europe, and Japan, where austerity measures and the growing use of generics will keep the compounded annual growth rates (CAGR) in the single digits, in the 1-4% …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial